Unusual Late Relapse of ALK-Positive Anaplastic Large Cell Lymphoma Successfully Cleared Using the ALK-Inhibitor Crizotinib: Case Report

Anaplastic large cell lymphoma (ALCL) with ALK-translocation constitutes an aggressive lymphoma with high sensitivity to anthracycline-based chemotherapy. Relapse, however, is observed in about one-third of patients. Salvage treatment incorporates high-dose chemotherapy followed by autologous or all...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Dennis Christoph Harrer, Karin Menhart, Stephanie Mayer, Wolfgang Herr, Albrecht Reichle, Martin Vogelhuber
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Frontiers Media S.A. 2020-10-01
Saila:Frontiers in Oncology
Gaiak:
crizotinib
anaplastic large cell lymphoma
ALK
relapse
hematology
Sarrera elektronikoa:https://www.frontiersin.org/article/10.3389/fonc.2020.585830/full
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak